Answer
Pregnancy use requires a clear benefit-risk justification. During breastfeeding, an individual decision is required because aztreonam enters milk and data for avibactam are lacking.
Sources for this answer
- Emblaveo 1.5 g/0.5 g powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- NHS Specialist Pharmacy ServiceNHS Specialist Pharmacy Service · NHS medicine guidance